CAINI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.303
EU - Europa 2.067
AS - Asia 402
AF - Africa 25
OC - Oceania 1
Totale 5.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.294
RU - Federazione Russa 777
PL - Polonia 336
SE - Svezia 277
IE - Irlanda 255
IT - Italia 138
CN - Cina 107
SG - Singapore 107
HK - Hong Kong 106
DE - Germania 82
UA - Ucraina 63
FI - Finlandia 57
GB - Regno Unito 39
TR - Turchia 36
IN - India 25
CI - Costa d'Avorio 23
BE - Belgio 12
JO - Giordania 11
VN - Vietnam 9
CA - Canada 8
CH - Svizzera 8
FR - Francia 8
NL - Olanda 8
CZ - Repubblica Ceca 4
NO - Norvegia 2
SC - Seychelles 2
AT - Austria 1
AU - Australia 1
KR - Corea 1
MX - Messico 1
Totale 5.798
Salva come PNG Salva come JPEG
Città #
Santa Clara 517
Fairfield 394
Warsaw 336
Chandler 280
Dublin 255
Ashburn 223
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Houston 129
Ann Arbor 115
Jacksonville 102
Singapore 82
Beijing 70
Princeton 61
Buffalo 56
Hong Kong 54
Altamura 50
Lawrence 45
Boardman 44
Boston 44
Izmir 35
Bremen 34
Medford 29
Florence 24
Mumbai 24
Abidjan 23
Shanghai 20
San Diego 19
Washington 15
Falls Church 13
Norwalk 13
Brussels 12
New York 11
Bern 8
Kent 7
Moscow 7
Munich 7
Hillsboro 6
Salerno 6
Toronto 6
West Jordan 6
Auburn Hills 5
Frankfurt Am Main 5
Los Angeles 5
Andover 4
Brno 4
London 4
Caserta 3
Milan 3
Old Bridge 3
Paris 3
Verona 3
Bastia umbra 2
Dong Ket 2
Grevenbroich 2
Laurel 2
Meppel 2
Oslo 2
Padova 2
Phoenix 2
Redmond 2
Rome 2
Aachen 1
Bergamo 1
Bologna 1
Brisbane 1
Catanzaro 1
Cattolica 1
Civitanova Marche 1
Clifton 1
Dearborn 1
Fuzhou 1
Genoa 1
Groningen 1
Guangzhou 1
Hanoi 1
Hefei 1
Incisa 1
Kunming 1
Leawood 1
Montréal 1
Mérida 1
Naaldwijk 1
Napanee 1
New Bedfont 1
Pune 1
Redwood City 1
San Mateo 1
Seoul 1
Stanford 1
Tappahannock 1
Vienna 1
Worcester 1
Yubileyny 1
Totale 3.976
Salva come PNG Salva come JPEG
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 248
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 181
The effects of phosphate on the contraction of single skeletal myofibrils 161
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 149
Host genetic determinants in HCV-related mixed cryoglobulinemia 142
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 140
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 137
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 127
Host genetic determinants in HCV-related mixed cryoglobulinemia 124
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 120
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 118
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 115
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 115
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 113
T(14;18) translocation in chronic hepatitis C virus infection 110
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 110
Involvement of PI3K in HCV-related lymphoproliferative disorders 110
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 110
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 108
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 104
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 104
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 102
Analysis of HCV persistence in patients with sustained virological response 102
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 102
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 102
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 102
Hepatitis C virus core protein enhances B lymphocyte proliferation 101
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 100
Host genetic determinants in HCV-related mixed cryoglobulinemia 99
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 96
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 95
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 95
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 92
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 91
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 91
Crioglobulinemia e linfoma in corso di infezione da HCV 88
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 87
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 81
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 80
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 77
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 76
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 72
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 72
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 70
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 70
Reply: HCV infection and psychopathological disorders 66
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 66
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 64
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 64
Eventi Oncomolecolari nella Crioglobulinemia Mista 64
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 63
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 61
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 54
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 52
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 51
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 50
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 49
null 48
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 46
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 46
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 41
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 37
Totale 5.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.755
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 0 0 97 105 94 108 96 92 77 13
2020/2021528 54 32 32 72 16 64 17 37 52 75 45 32
2021/2022431 4 49 15 15 15 17 16 30 21 9 90 150
2022/20231.154 100 152 75 108 114 226 152 59 124 8 21 15
2023/2024363 17 52 68 28 23 66 7 65 8 8 10 11
2024/20251.633 93 286 178 434 642 0 0 0 0 0 0 0
Totale 5.811